Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MPO | P05164 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | TACR1 | P25103 | 2/20 | 0.57 |
| ▸ | HTR2A | P28223 | 2/20 | 0.54 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | HTR1D | P28221 | 1/20 | 0.53 |
| ▸ | HTR1B | P28222 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.53 |
| ▸ | HTR1E | P28566 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4852920 | 0.90 | KDM4E (0.62) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL28548565 | 0.88 | KDM4E (0.61) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL10527492 | 0.88 | KDM4E (0.61) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL5481926 | 0.88 | KDM4E (0.61) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL475351 | 0.88 | MAPT (0.74) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL289044 | 0.88 | MAPT (0.74) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL5065255 | 0.87 | KDM4E (0.65) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL3857025 | 0.87 | KDM4E (0.52) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL4335856 | 0.85 | KDM4E (0.62) | KDM4EMAPTMEN1LMNAMPO | |
| SCHEMBL29701310 | 0.84 | KDM4E (0.58) | KDM4EMAPTMEN1LMNAMPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090105134-A1 | C-Terminally Pegylated Growth Hormones | NOVO NORDISK A/S (DK) | 2009-04-23 | — | — | US | claimed |
| US-20030104389-A1 | Synthesis of biologically active compounds in cells | SERGEEV PAVEL (CH) | 2003-06-05 | — | — | US | claimed |
| EP-1208219-A1 | SYNTHESIS OF BIOLOGICALLY ACTIVE COMPOUNDS IN CELLS | Sergeev, Pavel (CH) | 2002-05-29 | — | — | EP | claimed |
| WO-2000061775-A1 | SYNTHESIS OF BIOLOGICALLY ACTIVE COMPOUNDS IN CELLS | SERGEEV PAVEL (CH) | 2000-10-19 | — | — | WO | claimed |
| CN-111386050-B | Morbidity risk assessment device, morbidity risk assessment method, and computer-readable medium | 国立大学法人九州大学 | 2024-02-06 | — | — | CN | disclosed |
| CN-113397056-A | Feed for improving lean meat percentage of piglets and preparation method and application thereof | 长春禾丰饲料有限责任公司 | 2021-09-17 | — | — | CN | disclosed |
| CN-111386050-A | Disease risk evaluation device, disease risk evaluation method, program, and dementia prevention food | 国立大学法人九州大学 | 2020-07-07 | — | — | CN | disclosed |
| US-8795734-B2 | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-08-05 | — | — | US | disclosed |
| US-20130034610-A1 | HYDROPHOBIC NANOTUBES AND NANOPARTICLES AS TRANSPORTERS FOR THE DELIVERY OF DRUGS INTO CELLS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2013-02-07 | — | — | US | disclosed |
| US-8246995-B2 | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2012-08-21 | — | — | US | disclosed |
| US-7459443-B2 | Oligonucleotide sequences for use as viricide or antitumor agents; biosynthesis | SERGEEV PAVEL | 2008-12-02 | — | — | US | disclosed |
| US-20060275371-A1 | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells | UNIVERSITY, STANFORD | 2006-12-07 | — | — | US | disclosed |
| US-20050026143-A1 | Synthesis of biologically active compounds in cells | SERGEEV PAVEL (CH) | 2005-02-03 | — | — | US | disclosed |
| US-6831071-B2 | Oligonucleotide sequences for use as viricide or antitumor agents | SERGEEV PAVEL (CH) | 2004-12-14 | — | — | US | disclosed |
| WO-2004080920-A1 | HYDROPONIC PLANT NUTRIENT KIT AND METHOD OF USE | ADVANCED NUTRIENTS LTD. (CA) | 2004-09-23 | — | — | WO | disclosed |
| US-20030104389-A1 | Synthesis of biologically active compounds in cells | SERGEEV PAVEL (CH) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105134-A1 | C-Terminally Pegylated Growth Hormones | GHRHR, GHITM, HDGF | KDM4E 4141/4885MAPT 3647/4885MEN1 225/4885 |
| US-20050026143-A1 | Synthesis of biologically active compounds in cells | FBL, RNGTT, NOP2 | KDM4E 4491/4885MAPT 4003/4885MEN1 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.